Company intelligence / Profile preview

McFarlane Gordon

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

McFarlane Gordon Inc. was a prominent Canadian boutique investment bank and brokerage firm that specialized in the biotechnology and healthcare sectors. Founded in 1999 by Don McFarlane and Crawford Gordon, the firm provided a range of financial services, including corporate finance, equity research, and investment banking, specifically tailored to emerging life science companies. In 2003, the company was acquired by Jovian Capital Corp. and was later rebranded as MGI Securities in 2005. During its tenure, McFarlane Gordon played a significant role in the Canadian capital markets by advising and financing numerous biotech and healthcare ventures.

Industry: Investors

Beyond the preview

Go deeper on McFarlane Gordon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on McFarlane Gordon.

Explore the full profile